Personalized medicine will improve health outcomes and patient satisfaction and will be a predominant challenge for the pharmaceutical industry and regulatory science in the current century. Implementing personalized medicine based on individualsâ biological information is far from simple. Pharmacogenetics is the key to transform personalized medicine into clinical practice for diagnosis and prognosis. The use of pharmacogenetics in clinical practice, drug development, regulatory decision making, and post-market surveillance can facilitate the development of safer and more effective medicines and enhance the benefit-risk profile of approved drugs and the implementation of personalized medicine. Huixiao Hong, Next-Generation Sequencing and Its Impact on Pharmacogenetics.
Last date updated on June, 2014